Wealthier democracies or countries with especially restrictive HCQ protocols—Ireland, Canada, Spain, the Netherlands, UK, Belgium, and France—are comparatively deadly environments. Andrew Schlafly observed that, “The mortality rate from COVID-19 in countries that allow access to HCQ is only one-tenth the mortality rate in countries where there is interference with this medication, such as the United States. . . . In some areas of Central America, officials are even going door to door to distribute HCQ. . . . These countries have been successful in limiting the mortality from COVID-19 to only a
...more
